Tandem Diabetes Care, Inc.

J&J Ordered To Pay $1B For Breached Robotics Deal Johnson & Johnson owes $1bn to Auris Health, Inc. shareholders for breaching the terms of its 2019 acquisition of the robotics developer,

Abbott ’s continuous glucose monitoring technology will be integrated with Medtronic plc 's insulin dosing systems under a partnership announced on 7 August, marking a major strategic shift in Medtr

Dexcom perfectly timed a series of announcements with the start of this year’s annual Advanced Technologies & Treatments for Diabetes conference, held in Florence, Italy. On 5 March, the company anno

[ Editor's Note: Several of the companies mentioned in this story will be presenting at the JP Morgan Healthcare Conference in San Francisco over the coming days, so look for updates to follow. Med